In mouse models, TANs mediate the infiltration of regulatory T (Treg) cells and macrophages in the TME by secreting the chemokines CCL2 and CCL17, leading to the growth of hepatocellular carcinoma cells and increasing the resistance of hepatocellular carcinoma patients to sorafenib (51). This evidence concerns the gene CCL17 and hepatocellular carcinoma.